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In a cohort study of 49654 Canadian women, we assessed the association of colorectal cancer with total iron and heme iron intake,
excluding iron supplements. Among women aged 40–59 years, followed for an average of 16.4 years, we identified 617 incident
colorectal cancer cases. Data from a food frequency questionnaire administered at baseline were used to calculate red meat intake
and intake of total dietary iron, iron from meat, and heme iron. Analyses were carried out for all cases and for the proximal colon,
distal colon, and rectum, using Cox proportional hazards models. We found no association of intake of iron, heme iron, or iron from
meat with risk of colorectal cancer overall or with any of the subsites, nor was there effect modification by alcohol consumption or
hormonal replacement therapy.
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Free iron is a pro-oxidant, and may contribute to colorectal
carcinogenesis by promoting free radical production and lipid
peroxidation (Nelson, 1992; Toyokuni, 1996; Huang, 2003). Epide-
miologic studies examining the association of iron intake and
markers of body iron stores with risk of colorectal cancer or
colorectal polyps have yielded some evidence of positive associations
(Knekt et al, 1994; Bird et al, 1996; Wurzelmann et al, 1996; Tseng
et al, 1997; Kato et al, 1999). In addition, epidemiologic studies have
shown a modest association between red meat intake, the major
source of dietary iron, and risk of colon and colorectal cancer (Norat
and Riboli, 2001; Larsson and Wolk, 2006). However, few studies
have examined the association of intake of heme iron, derived
principally from red meat, with colorectal cancer risk. Heme iron,
which has greater bioavailability compared to non-heme iron, has
been shown experimentally to have cytotoxic and hyperproliferative
effects in the rat colon (Sesink et al, 1999). To date, three cohort
studies have reported on the association of heme iron intake and risk
of colon or colorectal cancer (Lee et al, 2004; Larsson et al,2 0 0 5 ;
Balder et al, 2006), and suggest a possible positive association of
intake with risk, which may be enhanced in consumers of alcohol.
However, there are inconsistencies in the association found in these
studies by subsite (Lee et al, 2004; Larsson et al, 2005) and by sex
(Balder et al, 2006), as well as with regard to the role of effect
modification by alcohol consumption. We used data from a large
cohort study of Canadian women to assess the risk of colorectal
cancer in association with total iron and heme iron intake, as well as
potential effect modification by alcohol consumption and hormone
replacement use.
METHODS AND MATERIALS
Study population
Our investigation was conducted in the Canadian National Breast
Screening Study (NBSS), a randomised controlled trial of screening
for breast cancer, which has been described in detail elsewhere
(Miller et al, 1992; Terry et al, 2002). In brief, 89835 women aged
40–59 years were recruited from the general Canadian population
between 1980 and 1985. On enrolment into the study, information
was obtained from participants on demographic, hormonal, and
reproductive characteristics using a self-administered lifestyle
questionnaire. Starting in 1982, a self-administered food frequency
questionnaire (FFQ) was distributed to all new attendees at all
screening centres and to women returning to the screening centres
for re-screening (Jain et al, 1982). The FFQ elicited information on
usual portion size and consumption of 86 food items, and included
photographs of portion sizes to assist respondents in quantifying
intake. A total of 49654 dietary questionnaires were returned and
were available for analysis. We excluded 929 women with extreme
energy intake values (at least three standard deviations above or
below the mean value for natural log-transformed calories) and
women whose body mass index (BMI) was o15 or 450kgm
 2 or
who were missing information on BMI.
Ascertainment of colorectal cancer and deaths
Incident cases of colorectal cancer and deaths from all causes were
ascertained, respectively, by means of computerised record
linkages to the Canadian Cancer Database and to the National
Mortality Database. The linkages to the databases yielded data on
cancer incidence and mortality up to 31 December 2000 for women
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December 1999 for women in other provinces. For the present
analyses, study participants were considered at risk from their date
of enrolment until the date of diagnosis of their colorectal cancer,
termination of follow-up (the date to which cancer incidence data
were available for women in the corresponding province), or
death, whichever occurred first. During an average of 16.4 years
(786588person-years) of follow-up of the dietary cohort, we
identified 617 incident colorectal cancer cases.
Computation of heme iron
Data from the FFQ were used to calculate total dietary iron intake
using a database described elsewhere (Jain et al, 1982). The values
for iron intake presented here are for dietary sources alone,
because data on iron supplements were not collected. Total intake
of meat iron was calculated from the reported intake of 22 meat
items and two mixed dishes containing meat. Heme iron intake
was computed by two methods, using different proportions for
heme iron from different types of meat: 69% for beef; 39% for
pork, ham, bacon, pork-based luncheon meats, and veal; 26% for
chicken and fish; 21% for liver, according to Balder et al (2006),
and, alternatively, using 40% as the average proportion of heme
iron in all meats, according to Lee et al (2004). Results were similar
for both methods, and we present data using the first approach.
Total iron and heme iron intake were calorie-adjusted using the
residuals method (Willett and Stampfer, 1986). In addition, we
assessed risk in association with meat iron intake, red meat intake,
and non-heme iron intake.
Statistical analysis
After exclusion of the 18 women with prevalent colorectal cancer at
baseline, and of those for the reasons described earlier, a total of
48666 women were available for analysis, among whom there were
617 incident colorectal cancer cases. Cox proportional hazards
models (using age as the time scale) were used to estimate hazard
ratios (HR) and 95% confidence intervals (CI) for the association
between iron intake and colorectal cancer risk. Quintiles of iron-
related variables were derived based on their distribution in the
total population. All multivariate models included the following
covariates: age (time to event variable); BMI (kgm
 2) (quintiles);
menopausal status (pre-, peri-, and postmenopausal); oral contra-
ceptive use (ever/never); hormone replacement use (ever/never);
dietary intakes of fat, fiber, folic acid, total calories (all
continuous); pack-years of smoking (neverþfive levels); alcohol
intake (never drinker, 40t oo5gday
 1,5t oo10gday
 1,1 0t o
o20gday
 1,2 0t oo30gday
 1,3 0t oo40gday
 1, and
40þgday
 1); education (three levels); physical activity (none,
moderate, vigorous, and missing). Addition of indicator variables
for screening centre (1–15) and randomisation group in the
original clinical trial (intervention/usual care) did not affect the
risk estimates, and therefore these variables were omitted. Because
an effect of iron or heme iron intake could be confounded by
intake of other dietary constituents with which they are correlated,
we included important food items (red meat, all meat, vegetables,
and raw vegetables) in additional models. Inclusion of these
variables did not affect the risk estimates for iron or heme iron,
and as a result they are not included in the final models. We
analysed the association of iron-related variables with colorectal
cancer overall and with cancers of the colon, proximal colon, distal
colon, and rectum. To test for trends in risk with increasing levels
of the exposures of interest, we assigned the median value for each
quintile and then fitted the medians as a continuous variable in the
risk models. We then evaluated the statistical significance of the
corresponding coefficient using the Wald test (Rothman and
Greenland, 1998). In additional analyses, we also treated iron-
related variables as continuous variables. Since early symptoms of
the disease might result in dietary change, we repeated the analyses
for colorectal cancer, excluding cases diagnosed during the first 3
years of follow-up.
We further examined the association of the iron-related
variables with colorectal cancer risk within strata of potential
effect modifiers: alcohol consumption (non-drinker; 1 to o20; and
20þ gday
 1) and hormone replacement therapy (HRT) use (ever/
never). Tests for interaction were based on the likelihood ratio
tests comparing models with and without the product terms
representing the variables of interest. All statistical significance
tests were two-sided. All analyses were performed using SAS
version 9 (SAS Institute Cary, NC, USA).
RESULTS
Cases tended to be older than non-cases, were more likely to be
postmenopausal, and were less likely to have used oral contra-
ceptives (Table 1). Cases and non-cases were similar in terms of
BMI, menstrual and reproductive variables, smoking, alcohol
consumption, and hormone replacement use.
In multivariate models adjusting for potential confounding
variables, quintiles of total iron intake, heme iron intake, and iron
intake from meat showed no association with colon cancer, rectal,
or colorectal cancer (Table 2). Intake of red meat was associated
with increased risk of rectal cancer (HR for highest vs lowest
quintile 1.95, 95% CI: 1.21–3.16, P-value for trend 0.008) but not
with risk of colon cancer or all colorectal cancer. No associations
or trends were seen when iron-related variables were treated as
continuous variables (data not shown). The same variables also
showed no associations with cancer of the proximal colon (218
cases) or distal colon (164 cases) (data not shown). When cases
diagnosed during the first 3 years of follow-up were excluded from
the analysis of colorectal cancer, the results were unchanged.
Total dietary iron intake was significantly correlated with intake
of vegetables (r¼0.49, Po0.0001), raw vegetables (r¼0.26,
Po0.0001), red meat (r¼0.30, Po0.0001), and intake of all meats
(r¼0.50, Po0.0001). Intake of heme iron was inversely correlated
with vegetable intake (r¼ 0.06) and positively correlated with
intakes of red meat (r¼0.51, Po0.0001) and all meats (r¼0.74,
Po0.0001). However, these foods were not associated with
colorectal cancer risk, and their inclusion in the models did not
alter the risk estimates for iron and heme iron.
Table 1 Baseline characteristics of the study population by outcome
Factor
Incident colorectal cancer
cases (n¼617)
Non-cases
(n¼48049)
Mean age at baseline (years) 51.1 (5.4) 48.5 (5.6)
Mean BMI (kgm
 2)
a 24.8 (4.2) 24.8 (4.2)
Mean age at first live birth
b 24.5 (4.1) 24.3 (4.8)
Parity (%)
Nulliparous 14.6 14.9
1–2 30.8 35.8
3–4 42.9 38.6
5+ 11.7 10.7
Postmenopausal (%) 53.0 37.2
Cigarette smoking
Never 50.2 53.3
Former 29.2 27.3
Current 20.6 19.3
Alcohol intake (% drinking
10+gday
 1 of alcohol)
29.0 26.4
Oral contraceptive use (% ever) 48.0 59.5
HRT use (% ever)
c 46.5 47.8
aBMI, body mass index.
bAmong parous women.
cHRT, hormone replacement
therapy; results among postmenopausal women only.
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colorectal cancer risk within strata of alcohol intake or hormone
replacement use (Table 3). The results for total iron intake, meat
iron intake, red meat intake, and non-heme iron intake were
similar (data not shown). Furthermore, there were no significant
interactions between heme iron intake and alcohol consumption or
HRT use (Table 3) or of other iron-related variables with these
potential effect modifiers.
DISCUSSION
The present analysis showed no association between dietary intake
of iron, heme iron, iron from meat sources, or non-heme iron and
risk of cancer of the colon, rectum, or proximal or distal colon.
Red meat intake was associated with increased risk of cancer of the
rectum, with evidence of a dose–response relationship. Previous
studies are suggestive of an association of red meat intake with
colorectal cancer, but the evidence is weak and inconsistent
(Potter, 1999). While potentially reflecting a real association, it is
also possible that the result for rectal cancer is a chance finding
due to the large number of comparisons. We found no association
of any of iron- or meat-related variables with colorectal cancer in
women who consumed any amount of alcohol or who consumed
20þ gday
 1, or in users of HRT.
Three previous studies that have assessed the association
between heme iron intake and colon or colorectal cancer have
yielded mixed results. In the Iowa Women’s Health Cohort, Lee
et al (2004) reported a positive association of heme iron with
proximal, but not distal, colon cancer, but only when zinc intake
was included in the model. The association was stronger in women
who consumed alcohol and strongest in women consuming
10þ gday
 1 of alcohol. Using data from the Swedish Mammo-
graphy Cohort, Larsson et al (2005) noted a statistically significant
positive association between heme iron intake and colon cancer
(principally distal colon cancer) in women who drank
20þ gweek
 1, but not in women drinking o20gweek
 1. Finally,
in an analysis of the Netherlands Cohort Study, Balder et al (2006)
found a positive association between heme iron intake and colon
cancer risk in men, but not in women, when cases diagnosed in the
first 2 years of follow-up were excluded, but they did not observe
an association with rectal cancer. The authors noted an increasing
trend in risk of colon cancer in men only with increasing levels of
the heme/chlorophyll ratio. They also reported finding a ‘sugges-
tion of an association’ of heme iron with colon and rectal cancer in
women who drank 45gday
 1 of alcohol. The studies by Lee et al
and Larsson et al used a fixed proportion of heme iron (40%) from
all types of meat, whereas Balder et al used differing proportions
for different types of meat. We found no association using either
method for calculation of heme iron.
Table 2 Multivariate-adjusted HR and 95% CI for the association of intake of iron-related variables with risk of incident cancer of the colon, rectum, and
colorectum
Multivariate HR
a (95% CI)
Colon cancer Rectal cancer Total colorectal cancer
Factor (n cases¼428) (n cases¼195) (n cases¼617
b)
Total iron (mgday
 1)
o11.90 1.00 (reference) 1.00 (reference) 1.00 (reference)
11.90 to o12.90 1.12 (0.82–1.54) 1.12 (0.71–1.78) 1.11 (0.86–1.44)
12.90 to o13.82 1.10 (0.81–1.52) 0.90 (0.55–1.48) 1.04 (0.80–1.36)
13.82 to o14.99 0.97 (0.69–1.36) 1.19 (0.74–1.92) 1.01 (0.77–1.34)
X14.99 1.07 (0.75–1.53) 1.12 (0.67–1.88) 1.07 (0.80–1.43)
P for trend 0.96 0.62 0.94
Heme iron (mgday
 1)
o1.58 1.00 (reference) 1.00 (reference) 1.00 (reference)
1.58 to o1.99 0.88 (0.64–1.19) 1.33 (0.82–2.15) 0.98 (0.75–1.27)
1.99 to o2.40 0.96 (0.71–1.30) 1.64 (1.03–2.62) 1.13 (0.87–1.45)
2.40 to o2.95 0.80 (0.57–1.12) 1.05 (0.62–1.78) 0.87 (0.65–1.15)
42.95 0.99 (0.70–1.40) 1.27 (0.74–2.19) 1.06 (0.80–1.42)
P for trend 0.99 0.71 0.99
Meat iron (mgday
 1)
o3.40 1.00 (reference) 1.00 (reference) 1.00 (reference)
3.40 to o4.23 1.02 (0.75–1.38) 0.96 (0.60–1.54) 1.00 (0.77–1.29)
4.23 to o5.02 0.94 (0.69–1.29) 1.39 (0.89–2.17) 1.06 (0.82–1.37)
5.02 to o6.11 0.86 (0.62–1.20) 0.76 (0.45–1.28) 0.84 (0.63–1.11)
X6.11 1.06 (0.75–1.49) 1.06 (0.64–1.75) 1.06 (0.80–1.41)
P for trend 0.87 0.88 0.84
Red meat (gday
 1)
o14.25 1.00 (reference) 1.00 (reference) 1.00 (reference)
14.25 to o21.02 1.06 (0.79–1.42) 1.25 (0.75–2.08) 1.10 (0.85–1.42)
21.02 to o28.74 0.97 (0.72–1.32) 1.79 (1.11–2.88) 1.17 (0.90–1.50)
28.74 to 40.30 0.84 (0.61–1.15) 1.42 (0.85–2.35) 0.97 (0.74–1.27)
40.30+ 0.88 (0.64–1.21) 1.95 (1.21–3.16) 1.12 (0.86–1.46)
P for trend 0.16 0.008 0.66
CI, confidence intervals; HR, hazard ratios.
aAdjusted for age (time to event variable); body mass index (kgm
 2) (quintiles); menopausal status (pre-, peri-, and postmenopausal);
oral contraceptive use (ever/never); hormone replacement use (ever/never); dietary intakes of fat, fibre, folic acid, total calories (continuous); pack-years of smoking (never+five
levels); alcohol intake (never drinker, 40t oo5, 5 to o10, 10 to o20, 20 to o30, 30 to o40, and 40+gday
 1); education (three levels); physical activity (none, moderate,
vigorous, and missing).
bSix women had a diagnosis of both colon and rectal cancer and were included in the analyses for both the colon and the rectum.
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the diet alone or from both diet and supplements, and markers of
body iron stores in relation to colorectal cancer risk. In a Finnish
cohort study, Knekt et al (1994) reported that participants with
transferrin saturation levels of greater than 60% had a relative risk
for colorectal cancer of 3.04 (95% CI: 1.64–5.62). In an analysis of
data from the National Health and Nutrition Examination Survey I
and the National Health Evaluation Follow-up Study (Wurzelmann
et al, 1996), participants in the highest quartile of dietary iron intake
were at increased risk for colon, but not rectal, cancer: relative risk
for males and females combined 3.35 (95% CI: 1.74–6.46). In the
same study, elevated serum iron was associated with increased risk
of distal colon cancer in women only (relative risk, 2.74; 95% CI:
0.82–9.20) and rectal cancer (relative risk, 7.31; 95% CI: 1.13–47.2),
whereas transferrin saturation levels and total iron binding capacity
(TIBC) were not associated with colorectal cancer. In a nested case–
control study carried out within a cohort of New York women (Kato
et al, 1999), no overall associations were seen for levels of serum
iron, ferritin, TIBC, transferrin saturation, or for iron intake
(dietþsupplements) with colorectal cancer. However, there was a
significant trend over increasing quartiles of iron intake for cancer
of the proximal colon (odds ratio for extreme quartiles 3.29; 95% CI:
0.7–14.6; P for trend¼0.04).
Our study has a number of strengths. The large sample size made
it possible to examine subsites within the colorectum. Follow-up of
the population is virtually complete. We used two different
approaches to estimating heme iron intake, with similar results,
and we considered a variety of potential confounding variables as
well as possible effect modification due to alcohol consumption and
hormone replacement use. However, a number of limitations should
also be pointed out. No information was available for iron derived
from nutritional supplements, which, in a cohort study from New
York (Kato et al, 1999), accounted for 38% of total iron intake.
Additionally, zinc intake, which in two studies (Lee et al, 2004;
Larsson et al, 2005) was inversely associated with risk of colon
cancer, was not estimated from the original dietary database used in
this study. Furthermore, only baseline questionnaire information
was available, so that it is possible that intake of nutrients, including
iron, changed over the long follow-up period, leading to non-
differential misclassification of exposure.
In summary, in this large prospective cohort study, we found no
suggestion of an association of iron or heme iron intake assessed at
baseline with risk of subsequent colorectal cancer or with risk of
cancer at subsites within the colorectum. Furthermore, there was
no evidence of effect modification by alcohol consumption or
hormone replacement use. To determine whether iron intake
contributes to the development of colorectal cancer, future studies
should improve on the assessment of iron intake by using repeat
measurements and obtaining information on use of iron-
containing supplements.
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